Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600) mutated melanoma: first data from a multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERINGMELANOMA

Michielin, O. and Richtig, E. and Grimmelmann, I and Loquai, C. and Forschner, A. and Hoeller, C. and Utikal, J. and Gutzmer, R. and Haferkamp, S. and Hassel, J. C. and Debus, D. and Fluck, M. and Goeppner, D. and Kehrer, H. and Dummer, R. and von Moos, R. and Thompson, J. and Milde, L. and Schadendorf, D. (2021) Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600) mutated melanoma: first data from a multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERINGMELANOMA. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User:	Petra Gürster
Date Deposited:	01 Dec 2022 10:15
Last Modified:	01 Dec 2022 10:15
URI:	https://pred.uni-regensburg.de/id/eprint/47965

Actions (login required)

View Item